The prevalence of cognitive impairment among patients with major depressive disorder was 54.4%, with significant risk factors including older age, lower education, unemployment, and illness relapse.
Cross-Sectional (n=395)
No
Cognitive impairment is highly prevalent (54.4%) among patients with major depressive disorder in Ethiopia, and is strongly associated with older age, lower education, unemployment, longer illness duration, and relapse.
OBJECTIVE: Cognitive impairments are now widely recognized and emerging as an important therapeutic target in a patient with a major depressive disorder (MDD). It associated with a more deteriorating course of illness among MDD patients. Therefore, understanding the level of cognitive impairment and associated factors is crucial to provide optimal care for MDD patients. RESULT: The proportion of cognitive impairment among MDD patients was found to be 54.4% (95%, CI (49.6, 59.3). Factors significantly associated with having cognitive impairment were age adjusted odds ratio (AOR) = 3.00, 95%, confidence interval (CI): (1.49, 6.03), educational status, (AOR = 5.36, 95% CI 2.16, 13.26), employment status (AOR = 3.63, 95 CI 1.99, 6.62), duration of the illness (AOR = 3.16, 95% CI 1.31, 7.64), having co-morbid psychiatric illnesses (AOR = 2.16, 95% CI 1.26, 3.71), and illness relapse (AOR = 2.97, 95% CI 1.54, 5.73).
Ambaw et al. (2019) conducted a cross-sectional in Major depressive disorder (n=395). Major depressive disorder was evaluated on Cognitive impairment (95% CI 49.6-59.3). The prevalence of cognitive impairment among patients with major depressive disorder was 54.4%, with significant risk factors including older age, lower education, unemployment, and illness relapse.